Abstract:Motivation: Computational drug repositioning is an important and efficient approach towards identifying novel treatments for diseases in drug discovery. The emergence of large-scale, heterogeneous biological and biomedical datasets has provided an unprecedented opportunity for developing computational drug repositioning methods. The drug repositioning problem can be modeled as a recommendation system that recommends novel treatments based on known drug-disease associations. The formulation under this recommendation system is matrix completion, assuming that the hidden factors contributing to drug-disease associations are highly correlated and thus the corresponding data matrix is low-rank. Under this assumption, the matrix completion algorithm fills out the unknown entries in the drug-disease matrix by constructing a low-rank matrix approximation, where new drug-disease associations having not been validated can be screened.Results: In this work, we propose a drug repositioning recommendation system (DRRS) to predict novel drug indications by integrating related data sources and validated information of drugs and diseases. Firstly, we construct a heterogeneous drug-disease interaction network by integrating drug-drug, disease-disease and drug-disease networks. The heterogeneous network is represented by a large drug-disease adjacency matrix, whose entries include drug pairs, disease pairs, known drug-disease interaction pairs and unknown drug-disease pairs. Then, we adopt a fast Singular Value Thresholding (SVT) algorithm to complete the drug-disease adjacency matrix with predicted scores for unknown drug-disease pairs. The comprehensive experimental results show that DRRS improves the prediction accuracy compared with the other state-of-the-art approaches. In addition, case studies for several selected drugs further demonstrate the practical usefulness of the proposed method.Availability and implementation: http://bioinformatics.csu.edu.cn/resources/softs/DrugRepositioning/DRRS/index.html.Contact: yaohang@cs.odu.edu or jxwang@mail.csu.edu.cn.Supplementary information: Supplementary data are available at Bioinformatics online.

Mining Drug–disease Relationships As a Complement to Medical Genetics‐based Drug Repositioning: Where a Recommendation System Meets Genome‐wide Association Studies

Mining Drug-Disease Relationships:A Recommendation System

Computational Approaches for Predicting Drug-Disease Associations: A Comprehensive Review

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

Predicting drug-disease associations by network embedding and biomedical data integration.

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Drug Repositioning Through Integration of Prior Knowledge and Projections of Drugs and Diseases

Drug Repurposing by Integrated Literature Mining and Drug-Gene-Disease Triangulation

Machine learning for drug repositioning: Recent advances and challenges

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

Computational Drug Repositioning Using Meta-Path-based Semantic Network Analysis.

Computational Drug Repositioning Using Collaborative Filtering Via Multi-Source Fusion

Computational drug repositioning: from data to therapeutics.

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

Systems Chemical Genetics-Based Drug Discovery: Prioritizing Agents Targeting Multiple/Reliable Disease-Associated Genes as Drug Candidates

Author Correction: Prediction of New Drug Indications Based on Clinical Data and Network Modularity

Semi-supervised Graph Cut Algorithm for Drug Repositioning by Integrating Drug, Disease and Genomic Associations.

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.

In silico drug repositioning based on drug-miRNA associations

Biomedical Data and Computational Models for Drug Repositioning: a Comprehensive Review